Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Luckily for you, we at StockStory have no conflicts of interest - our sole job is to help you find genuinely promising companies. Keeping that in mind, here is one stock where Wall Street’s positive outlook is supported by strong fundamentals and two where consensus estimates seem disconnected from reality.
Two Stocks to Sell:
Deckers (DECK)
Consensus Price Target: $126.86 (21.7% implied return)
Established in 1973, Deckers (NYSE: DECK) is a footwear and apparel conglomerate with a portfolio of lifestyle and performance brands.
Why Do We Avoid DECK?
- Underwhelming constant currency revenue performance over the past two years suggests its product offering at current prices doesn’t resonate with customers
- Operating margin of 23.4% falls short of the industry average, and the smaller profit dollars make it harder to react to unexpected market developments
- Projected 5.1 percentage point decline in its free cash flow margin next year reflects the company’s plans to increase its investments to defend its market position
Deckers’s stock price of $104.25 implies a valuation ratio of 13.4x forward P/E. If you’re considering DECK for your portfolio, see our FREE research report to learn more.
Universal Health Services (UHS)
Consensus Price Target: $215.76 (36.3% implied return)
With a network spanning 39 states and three countries, Universal Health Services (NYSE: UHS) operates acute care hospitals and behavioral health facilities across the United States, United Kingdom, and Puerto Rico.
Why Are We Wary of UHS?
- Weak comparable store sales trends over the past two years suggest there may be few opportunities in its core markets to open new facilities
- Lacking free cash flow generation means it has few chances to reinvest for growth, repurchase shares, or distribute capital
Universal Health Services is trading at $158.28 per share, or 6.3x forward P/E. Dive into our free research report to see why there are better opportunities than UHS.
One Stock to Buy:
Netflix (NFLX)
Consensus Price Target: $114.15 (47% implied return)
Launched by Reed Hastings as a DVD mail rental company until its famous pivot to streaming in 2007, Netflix (NASDAQ: NFLX) is a pioneering streaming content platform.
What Makes NFLX Stand Out?
- Has the opportunity to boost monetization through new features and premium offerings as its global streaming paid memberships have grown by 15.6% annually over the last two years
- Share repurchases have amplified shareholder returns as its annual earnings per share growth of 49.2% exceeded its revenue gains over the last three years
- Free cash flow margin grew by 16.2 percentage points over the last few years, giving the company more chips to play with
At $77.63 per share, Netflix trades at 17.9x forward EV/EBITDA. Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
